山西永津集團(tuán)有限公司穩(wěn)定供應(yīng)2,3 - 二氯喹喔啉（CAS2213-63-0，別名 2,3 - 二氯喹惡啉、2,3 - 二氯苯并吡嗪），產(chǎn)品純度穩(wěn)定≥99%，灰色結(jié)晶固體，雜質(zhì)含量低、批次一致性強(qiáng)，可提供全套 COA 質(zhì)檢報(bào)告、合規(guī)資質(zhì)文件，支持 1kg 試樣、25kg 紙板桶標(biāo)準(zhǔn)包裝及噸級(jí)大批量現(xiàn)貨直發(fā)。本品屬于高活性氯代喹喔啉雜環(huán)單體，可發(fā)生親核芳香取代反應(yīng)，下游應(yīng)用覆蓋多核心行業(yè)：醫(yī)藥領(lǐng)域是喹喔啉類衍生物核心合成原料，用于抗腫瘤、防癌先導(dǎo)藥物、抗炎抗病毒原料藥制備，也用于心腦血管、抑菌類新藥合成；分析化學(xué)領(lǐng)域用于固相合成制備 HPLC 高效液相手性固定相，色譜分離填料關(guān)鍵中間體；電子新材料行業(yè)作為液晶顯示材料、有機(jī)光電薄膜合成單體；農(nóng)藥領(lǐng)域合成廣譜抑菌、除草類雜環(huán)農(nóng)藥及植物病害防治中間體；精細(xì)有機(jī)合成用于各類單取代、雙取代喹喔啉衍生物搭建；科研實(shí)驗(yàn)室用作有機(jī)合成標(biāo)準(zhǔn)底物、新藥研發(fā)模板原料；同時(shí)可制備甾體稠合喹喔啉雜環(huán)、硫代嘧啶類醫(yī)藥中間體。集團(tuán)自有標(biāo)準(zhǔn)化雜環(huán)化工生產(chǎn)線，庫(kù)存充足、交付周期短，長(zhǎng)期為國(guó)內(nèi)外制藥、光電液晶、農(nóng)藥、色譜試劑企業(yè)穩(wěn)定供貨。

Shanxi Yongjin Group Co., Ltd. stably supplies 2,3-Dichloroquinoxaline (CAS 2213-63-0, also named 2,3-dichloroquinoxazoline, 2,3-dichlorobenzopyrazine) with purity over 99%. It is gray crystalline solid with low impurities and consistent batch indicators. We provide full COA test certificates and compliance documents, supporting 1kg lab samples, 25kg fiber drum standard packages and bulk ton-level spot delivery. As highly active chlorinated quinoxaline heterocyclic monomer, it undergoes nucleophilic aromatic substitution reaction, widely applied in multiple core industries: In pharmaceutical field, it is core raw material for quinoxaline derivatives, applied in anti-tumor, cancer chemopreventive lead compounds, anti-inflammatory and antiviral APIs, as well as cardiovascular and antibacterial new drugs; In analytical chemistry, it is adopted in solid-phase synthesis to manufacture HPLC chiral stationary phases, key intermediate for chromatographic separation fillers; For electronic new materials, it serves as synthetic monomer for liquid crystal display materials and organic optoelectronic films; In pesticide industry, it synthesizes broad-spectrum bacteriostatic, herbicidal heterocyclic pesticides and crop disease control intermediates; For fine organic synthesis, it builds various mono- and disubstituted quinoxaline derivatives; In research labs, it acts as standard substrate for organic synthesis and template raw material for new drug research; It can also synthesize steroid fused quinoxaline heterocycles and thiopyrimidine pharmaceutical intermediates. Our group owns standardized heterocyclic chemical production lines with sufficient inventory and short lead time, offering long-term stable supply for pharmaceutical, optoelectronic liquid crystal, pesticide and chromatographic reagent enterprises worldwide.